Outcome of Board Meeting held on 30th May, 2026

Boston Commerce Limited (formerly Boston Bio Systems Limited) reported its audited standalone financial results for the quarter and year ended March 31, 2026. The company posted a net loss of Rs 58.08 lakhs for FY26 compared to a loss of Rs 54.73 lakhs in FY25, indicating a slight deterioration in profitability. Total income was Rs 19.25 lakhs while total expenses stood at Rs 68.30 lakhs, driven significantly by finance costs of Rs 59.23 lakhs. The auditors issued an unmodified opinion on the financial statements. The auditor's report notably flagged that the company has not made any TDS payments during FY25-26 as required under the Income Tax Act. Total assets declined to Rs 736.50 lakhs from Rs 1,490.37 lakhs in the prior year, while borrowings decreased substantially from Rs 459.29 lakhs to zero in non-current liabilities.